1 Citation, commencement and interpretation

(1)    These Regulations may be cited as the National Health Service (Functions of Strategic Health Authorities and Primary Care Trusts and Administration Arrangements) (England) (Amendment) Regulations 2011 and shall come into force on 1st April 2011.

(2)    In these Regulations, “the principal Regulations” means the National Health Service (Functions of Strategic Health Authorities and Primary Care Trusts and Administration Arrangements) (England) Regulations 2002.

NOTES
Initial Commencement
Specified date

Specified date: 1 April 2011: see para (1) above.

2 Substitution of Schedule 5 to the principal Regulations

2Substitution of Schedule 5 to the principal Regulations

For Schedule 5 to the principal Regulations (Secretary of State's functions under section 3(1) of the National Health Service Act 2006 exercisable by Strategic Health Authorities for the purpose of securing the provision of services: specified services) substitute the following Schedule—

“SCHEDULE 5
Secretary of State's Functions Under Section 3(1) of The National Health Service Act 2006 Exercisable by Strategic Health Authorities for the Purpose of Securing the Provision of Services: Specified Services Regulation 3(2A)
1Alström syndrome service
2Ataxia telangiectasia service for children
3Autoimmune paediatric gut syndromes service
4Autologous intestinal reconstruction in adult patients
5Bardet-Biedl syndrome service
6Barth syndrome service
7Bladder exstrophy service
8Choriocarcinoma service
9Chronic pulmonary aspergillosis service
10Complex childhood osteogenesis imperfecta
11Complex Ehlers Danlos syndrome service
12Complex neurofibromatosis type 1 service
13Complex tracheal disease service
14Congenital hyperinsulinism service
15Craniofacial service
16Cryopyrin associated periodic syndrome service
17Diagnostic service for amyloidosis
18Diagnostic service for primary ciliary dyskinesia
19Diagnostic service for rare neuromuscular disorders service
20Encapsulating sclerosing peritonitis surgical service
21Epidermolysis bullosa service
22Extra corporeal membrane oxygenation service for adults
23Extra corporeal membrane oxygenation service for neonates, infants and children with respiratory failure
24Gender identity development service for children and adolescents
25Heart and lung transplantation service (including bridge to transplant using mechanical circulatory support)
26Insulin-resistant diabetes service
27Islet transplantation service
28Liver transplantation service
29Lymphangioleiomyomatosis
30Lysosomal storage disorder service
31McArdle's disease service
32Mental health service for deaf children and adolescents
33Neurofibromatosis type 2 service
34Neuromyelitis optica service
35Ocular oncology service
36Ophthalmic pathology service
37Osteo-odonto-keratoprosthesis service for corneal blindness
38Pancreas transplantation service
39Paroxysmal nocturnal haemoglobinuria service
40Paediatric intestinal pseudo-obstructive disorders
41Primary malignant bone tumours service
42Proton beam therapy service
43Pseudomyxoma peritonei service
44Pulmonary hypertension service for children
45Pulmonary thromboendarterectomy service
46Rare mitochondrial disorders service
47Reconstructive surgery service for adolescents for congenital malformation of the female genital tract
48Retinoblastoma service
49Secure forensic mental health service for young people
50Severe combined immunodeficiency and related disorders service
51Severe intestinal failure service
52Severe obsessive compulsive disorder and body dysmorphic disorder service
53Small bowel transplantation service
54Specialist paediatric liver disease service
55Stem cell transplantation service for juvenile idiopathic arthritis and related connective tissue disorders
56Stickler syndrome diagnostic service
57Vein of Galen malformation service
58Veterans' post-traumatic stress disorder programme
59Wolfram syndrome
60Xeroderma pigmentosum service.”
NOTES
Initial Commencement
Specified date

Specified date: 1 April 2011: see reg 1(1).

Signature

Signed by authority of the Secretary of State for Health.

Earl Howe

Parliamentary Under-Secretary of State,

Department of Health

23rd February 2011

EXPLANATORY NOTE

EXPLANATORY NOTE (This note is not part of the Regulations)

These Regulations, which apply in relation to England, further amend the National Health Service (Functions of Strategic Health Authorities and Primary Care Trusts and Administration Arrangements) (England) Regulations 2002 (“the principal Regulations”).

Regulation 2 substitutes a new Schedule 5 to the principal Regulations. Schedule 5 lists the specialised services whose provision is to be secured in England by Strategic Health Authorities, rather than Primary Care Trusts. The revised list adds new services that Strategic Health Authorities may commission.

The new services are—

—Autologous intestinal reconstruction in adult patients (item 4)

—Complex childhood osteogenesis imperfecta (item 10)

—Insulin-resistant diabetes service (item 26)

—Lymphangioleiomyomatosis (item 29)

—Paediatric intestinal pseudo-obstructive disorders (item 40)

—Stickler syndrome diagnostic service (item 56)

—Veterans' post-traumatic stress disorder programme (item 58)

—Wolfram syndrome (item 59).

A full impact assessment has not been produced for this instrument as no impact on the private or voluntary sectors is foreseen.

Lexis®Library

  • Cases related to this particular case that are related to, or discuss this caseView related cases
  • Halsbury's SI CitatorHalsbury's SI Citator
  • The current law in England and Wales, consolidated by the incorporation of amendments into existing legislation, by an expert team of editorsView Consolidated Version
  • Commentary discussing this particular case from LexisLibrary's comprehensive range of titles including Butterworths, Halsbury's and TolleyView all related commentary